COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:CBHD - DK0060448595 - Common Stock
77.82 EUR
+0.96 (+1.25%)
Taking everything into account, CBHD scores 5 out of 10 in our fundamental rating. CBHD was compared to 60 industry peers in the Health Care Equipment & Supplies industry. While CBHD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CBHD is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
CBHD had positive earnings in the past year.
In the past year CBHD had a positive cash flow from operations.
In the past 5 years CBHD has always been profitable.
CBHD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CBHD has a Return On Assets of 7.52%. This is amongst the best in the industry. CBHD outperforms 81.67% of its industry peers.
CBHD's Return On Equity of 22.55% is amongst the best of the industry. CBHD outperforms 91.67% of its industry peers.
With an excellent Return On Invested Capital value of 12.65%, CBHD belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
CBHD had an Average Return On Invested Capital over the past 3 years of 13.59%. This is above the industry average of 8.99%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROIC | 12.65% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
1.3 Margins
Looking at the Profit Margin, with a value of 13.04%, CBHD is in the better half of the industry, outperforming 78.33% of the companies in the same industry.
In the last couple of years the Profit Margin of CBHD has declined.
With an excellent Operating Margin value of 27.52%, CBHD belongs to the best of the industry, outperforming 96.67% of the companies in the same industry.
CBHD's Operating Margin has declined in the last couple of years.
CBHD has a better Gross Margin (67.97%) than 75.00% of its industry peers.
In the last couple of years the Gross Margin of CBHD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% |
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CBHD is creating value.
CBHD has about the same amout of shares outstanding than it did 1 year ago.
CBHD has more shares outstanding than it did 5 years ago.
CBHD has a better debt/assets ratio than last year.
2.2 Solvency
CBHD has an Altman-Z score of 3.95. This indicates that CBHD is financially healthy and has little risk of bankruptcy at the moment.
CBHD has a better Altman-Z score (3.95) than 71.67% of its industry peers.
CBHD has a debt to FCF ratio of 4.34. This is a neutral value as CBHD would need 4.34 years to pay back of all of its debts.
CBHD has a Debt to FCF ratio (4.34) which is in line with its industry peers.
CBHD has a Debt/Equity ratio of 1.24. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.24, CBHD is not doing good in the industry: 85.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Altman-Z | 3.95 |
ROIC/WACC2.2
WACC5.76%
2.3 Liquidity
A Current Ratio of 1.61 indicates that CBHD should not have too much problems paying its short term obligations.
The Current ratio of CBHD (1.61) is comparable to the rest of the industry.
CBHD has a Quick Ratio of 1.00. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
CBHD has a Quick ratio of 1.00. This is in the lower half of the industry: CBHD underperforms 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
CBHD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -39.34%.
CBHD shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.08% yearly.
CBHD shows a small growth in Revenue. In the last year, the Revenue has grown by 3.12%.
The Revenue has been growing by 8.49% on average over the past years. This is quite good.
EPS 1Y (TTM)-39.34%
EPS 3Y-14.9%
EPS 5Y-7.08%
EPS Q2Q%-92.22%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%1.74%
3.2 Future
Based on estimates for the next years, CBHD will show a very strong growth in Earnings Per Share. The EPS will grow by 23.56% on average per year.
The Revenue is expected to grow by 7.53% on average over the next years.
EPS Next Y89.92%
EPS Next 2Y45.02%
EPS Next 3Y35.02%
EPS Next 5Y23.56%
Revenue Next Year5.7%
Revenue Next 2Y6.56%
Revenue Next 3Y7.67%
Revenue Next 5Y7.53%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
CBHD is valuated quite expensively with a Price/Earnings ratio of 42.76.
CBHD's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 25.45. CBHD is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 22.46 indicates a rather expensive valuation of CBHD.
CBHD's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.46, CBHD is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.76 | ||
| Fwd PE | 22.46 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CBHD is on the same level as its industry peers.
73.33% of the companies in the same industry are more expensive than CBHD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.41 | ||
| EV/EBITDA | 15.6 |
4.3 Compensation for Growth
CBHD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CBHD has a very decent profitability rating, which may justify a higher PE ratio.
CBHD's earnings are expected to grow with 35.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.48
PEG (5Y)N/A
EPS Next 2Y45.02%
EPS Next 3Y35.02%
5. Dividend
5.1 Amount
CBHD has a Yearly Dividend Yield of 3.82%.
Compared to an average industry Dividend Yield of 2.11, CBHD pays a better dividend. On top of this CBHD pays more dividend than 98.33% of the companies listed in the same industry.
CBHD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.82% |
5.2 History
The dividend of CBHD has a limited annual growth rate of 5.30%.
Dividend Growth(5Y)5.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CBHD pays out 136.36% of its income as dividend. This is not a sustainable payout ratio.
CBHD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP136.36%
EPS Next 2Y45.02%
EPS Next 3Y35.02%
FRA:CBHD (11/21/2025, 7:00:00 PM)
77.82
+0.96 (+1.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners29.27%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap16.36B
Revenue(TTM)27.87B
Net Income(TTM)3.64B
Analysts68.46
Price Target92.01 (18.23%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.82% |
Yearly Dividend2.95
Dividend Growth(5Y)5.3%
DP136.36%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.58%
Min EPS beat(2)-92.81%
Max EPS beat(2)-22.36%
EPS beat(4)0
Avg EPS beat(4)-36.47%
Min EPS beat(4)-92.81%
Max EPS beat(4)-15.32%
EPS beat(8)0
Avg EPS beat(8)-20.36%
EPS beat(12)0
Avg EPS beat(12)-16.18%
EPS beat(16)1
Avg EPS beat(16)-13.67%
Revenue beat(2)0
Avg Revenue beat(2)-1.66%
Min Revenue beat(2)-2.12%
Max Revenue beat(2)-1.2%
Revenue beat(4)0
Avg Revenue beat(4)-1.32%
Min Revenue beat(4)-2.12%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.17%
Revenue beat(12)1
Avg Revenue beat(12)-1.38%
Revenue beat(16)4
Avg Revenue beat(16)-0.85%
PT rev (1m)-2.64%
PT rev (3m)-8.24%
EPS NQ rev (1m)9.43%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.05%
EPS NY rev (3m)-10.56%
Revenue NQ rev (1m)2.72%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)-2.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.76 | ||
| Fwd PE | 22.46 | ||
| P/S | 4.38 | ||
| P/FCF | 23.41 | ||
| P/OCF | 18.39 | ||
| P/B | 7.58 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.6 |
EPS(TTM)1.82
EY2.34%
EPS(NY)3.46
Fwd EY4.45%
FCF(TTM)3.32
FCFY4.27%
OCF(TTM)4.23
OCFY5.44%
SpS17.75
BVpS10.27
TBVpS-8.72
PEG (NY)0.48
PEG (5Y)N/A
Graham Number20.51
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROCE | 18.32% | ||
| ROIC | 12.65% | ||
| ROICexc | 12.94% | ||
| ROICexgc | 47.68% | ||
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% | ||
| FCFM | 18.72% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
ROICexc(3y)13.93%
ROICexc(5y)19.56%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.68%
ROCE(5y)29.74%
ROICexgc growth 3Y-12.46%
ROICexgc growth 5Y-4.64%
ROICexc growth 3Y-7.18%
ROICexc growth 5Y-21.95%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Debt/EBITDA | 2.2 | ||
| Cap/Depr | 98.21% | ||
| Cap/Sales | 5.12% | ||
| Interest Coverage | 9.3 | ||
| Cash Conversion | 72.84% | ||
| Profit Quality | 143.51% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 3.95 |
F-Score6
WACC5.76%
ROIC/WACC2.2
Cap/Depr(3y)106.21%
Cap/Depr(5y)137.78%
Cap/Sales(3y)5.05%
Cap/Sales(5y)6.06%
Profit Quality(3y)77.98%
Profit Quality(5y)77.41%
High Growth Momentum
Growth
EPS 1Y (TTM)-39.34%
EPS 3Y-14.9%
EPS 5Y-7.08%
EPS Q2Q%-92.22%
EPS Next Y89.92%
EPS Next 2Y45.02%
EPS Next 3Y35.02%
EPS Next 5Y23.56%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%1.74%
Revenue Next Year5.7%
Revenue Next 2Y6.56%
Revenue Next 3Y7.67%
Revenue Next 5Y7.53%
EBIT growth 1Y5.27%
EBIT growth 3Y3.54%
EBIT growth 5Y5.55%
EBIT Next Year28.29%
EBIT Next 3Y15.9%
EBIT Next 5Y12.37%
FCF growth 1Y268.5%
FCF growth 3Y9.61%
FCF growth 5Y6.39%
OCF growth 1Y140.59%
OCF growth 3Y9.24%
OCF growth 5Y6.9%
COLOPLAST-B / CBHD.DE FAQ
What is the ChartMill fundamental rating of COLOPLAST-B (CBHD.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CBHD.DE.
What is the valuation status for CBHD stock?
ChartMill assigns a valuation rating of 5 / 10 to COLOPLAST-B (CBHD.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for COLOPLAST-B?
COLOPLAST-B (CBHD.DE) has a profitability rating of 7 / 10.
Can you provide the financial health for CBHD stock?
The financial health rating of COLOPLAST-B (CBHD.DE) is 4 / 10.
What is the expected EPS growth for COLOPLAST-B (CBHD.DE) stock?
The Earnings per Share (EPS) of COLOPLAST-B (CBHD.DE) is expected to grow by 89.92% in the next year.